Citi Slashes CAT Target, Lifts West Pharma by $82
Citigroup drove the bulk of analyst activity on Sunday, issuing a wave of target price revisions across industrials, healthcare, and financials. The sharpest cut fell on CAT. Analyst Kyle Menges trimmed his target from…